ArticleEJHaem2022

Unmet needs in the management of immune-mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK-A modified-Delphi study.

Marie Scully et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.